Hexarelin is a synthetic hexapeptide that emerged from late-20th-century efforts to design growth hormone–releasing peptides ...
Vepdegestrant becomes the first FDA-approved heterobifunctional protein degrader (PROTAC) in breast cancer, targeting ER ...
Within the expanding landscape of synthetic peptide research, Examorelin has attracted sustained attention as a structurally ...
Hormonal regulation plays a fundamental role in maintaining physiological homeostasis, modulating processes such as metabolism, stress response, ...
Within the expanding landscape of peptide science, AOD-9604 occupies a distinctive conceptual niche. Derived as a functional ...
Peptide hormones and bile acids shaping immune tolerance of the liver: implications and applications
The exceptional immune tolerance of the liver is, in part, mediated by entero-pancreatic endocrine factors that enter the portal vein at elevated levels. These endocrine factors signal via cAMP, ...
In some cases, HR-positive/HER2-negative breast cancers may over time become resistant to endocrine therapy. This can occur through mutations in the estrogen receptor ...
The Red & Black is a 501c3 nonprofit. Please consider a one-time gift or become a monthly supporter. Cancel anytime. Sermorelin is a synthetic peptide analog of growth hormone‑releasing hormone (GHRH) ...
CDK 4/6 inhibitors (CDK4/6i) remain part of the standard first-line treatment for patients with hormone receptor–positive metastatic breast cancer, offering demonstrable improvements in both ...
FDA has approved vepdegestrant (VEPPANU), the first PROTAC therapy, for adults with ESR1-mutated ER+/HER2- advanced or ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results